LPS signal transduction: The picture is becoming more complex

Current Topics in Medicinal Chemistry

Volumn 4, Issue 11, 2004, Pages 1115-1126

  Diks, Sander H ^a   Richel, Dick J ^a   Peppelenbosch, Maikel P ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Lipopolysaccharide; Signal transduction; Signalosome

Indexed keywords

ANTIBIOTIC AGENT; BACTERICIDAL PERMEABILITY INCREASING PROTEIN; BACTERIUM LIPOPOLYSACCHARIDE; CD4 ANTIGEN; COMPLEMENT RECEPTOR; ENDOTOXIN; GROWTH DIFFERENTIATION FACTOR 5; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 90; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 6; LIPID A DERIVATIVE; LIPID BINDING PROTEIN; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; MYELOID DIFFERENTIATION FACTOR 88; PHOSPHATIDYLINOSITOL 3 KINASE; PROBIOTIC AGENT; RECOMBINANT BACTERICIDAL PERMEABILITY INCREASING PROTEIN; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; SCAVENGER RECEPTOR; SOLUBLE CD4 ANTIGEN; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; UNINDEXED DRUG; WORTMANNIN;

ANTIINFLAMMATORY ACTIVITY; BACTERICIDAL ACTIVITY; CELLULAR IMMUNITY; CLINICAL TRIAL; DRUG DESIGN; ENDOCYTOSIS; ENZYME ACTIVATION; GRAM NEGATIVE INFECTION; HUMAN; IMMUNE RESPONSE; MOLECULAR MECHANICS; MOLECULAR RECOGNITION; NONHUMAN; PHAGOCYTOSIS; PLASMA PROTEIN BINDING; REVIEW; SEPSIS; SEPTIC SHOCK; SIGNAL TRANSDUCTION;

ANIMALS; ANTIGENS, CD14; HUMANS; IMMUNITY, NATURAL; LIPOPOLYSACCHARIDES; MEMBRANE GLYCOPROTEINS; RECEPTORS, CELL SURFACE; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS;

EID: 3142659001     PISSN: 15680266     EISSN: None     Source Type: Journal    
DOI: 10.2174/1568026043388141     Document Type: Review

References (138)

1. Dangl, J. L.; Jones, J. D. Plant pathogens and integrated defence responses to infection. Nature 2001, 411, 826-833.
2. Inohara, N.; Ogura, Y.; Nunez, G. Nods: a family of cytosolic proteins that regulate the host response to pathogens. Curr. Opin. Microbiol. 2002, 5, 76-80.
3. Jebanathirajah, J. A.; Peri, S.; Pandey, A. Toll and interleukin-1 receptor [TIR] domain-containing proteins in plants: a genomic perspective. Trends Plant Sci. 2002, 7, 388-391.
4. Fallon, P. G.; Allen, R. L.; Rich, T. Primitive Toll signalling: bugs, flies, worms and man. Trends Immunol. 2001, 22, 63-66.
5. Hashimoto, C.; Hudson, K. L.; Anderson, K. V. The Toll gene of Drosophila, required for dorsal-ventral embryonic polarity, appears to encode a transmembrane protein. Cell 1988, 52, 269-279
6. Lemaitre, B.; Nicolas, E.; Michaut, L.; Reichhart, J. M.; Hoffmann, J. A. The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell 1996, 86, 973-983.
7. Vogel, G. Fly development genes lead to immune find. Science 1998, 281, 1942-1944.
8. Akira, S. Toll-like receptors: lessons from knockout mice. Biochem. Soc. Trans. 2000, 28, 551-556.
9. Pfeiffer, R. Untersuchungen uber das Choleragift. Z. Hygiene 1892, 11, 393-412.
10. Boivin, A. Traveaux recents sur la constitution chimique et su les proprietes biologiques des antigens bacteriens. Schweiz. Z. Pathol. Bakteriol. 1946, 9, 505-41
11. Luderitz, O.; Galanos, C.; Lehman V.; Nurminen, M.; Rietschel, E. T.; Rosenfelder, G.; Simon, M.; Westphal, O. Lipid A: chemical structure and biological activity. J. Infect. Dis. 1973, 128, 17-29
12. Raetz, C. R. Biochemistry of endotoxins. Annu. Rev. Biochem. 1990, 59, 129-170.
13. Janeway, C. A., Jr.; Medzhitov, R. Introduction: the role of innate immunity in the adaptive immune response. Semin. Immunol. 1998, 10, 349-350.
14. Barton, G. M.; Medzhitov, R. Toll-like receptors and their ligands. Curr. Top. Microbiol. Immunol. 2002, 270, 81-92.
15. Berczi, I.; Bertok, L.; Bereznai, T. Comparative studies on the toxicity of Escherichia coli lipopolysaccharide endotoxin in various animal species. Can. J. Microbiol. 1966, 12, 1070-1071.
16. Beutler, B. Innate immune responses to microbial poisons: Discovery and Function of the Toll-Like Receptors. Annu. Rev. Pharmacol. Toxicol. 2003, 43, 609-628.
17. Schumann, R. R.; Leong, S. R.; Flaggs, G. W.; Gray, P. W.; Wright, S. D. Mathison, J. C.; Tobias, P. S.; Ulevitch, R. J. Structure and function of lipopolysaccharide binding protein. Science 1990, 249, 1429-1431.
18. Tobias, P. S.; Soldau, K.; Gegner, J. A.; Mintz, D.; Ulevitch, R. J. Lipopolysaccharide binding protein-mediated complexation of lipopolysaccharide with soluble CD14. J. Biol. Chem. 1995, 270, 10482-10488.
19. Yu, B.; Wright, S. D. Catalytic properties of lipopolysaccharide (LPS) binding protein. Transfer of LPS to soluble CD14. J. Biol. Chem. 1996, 271, 4100-4105.
20. Yu, B.; Hailman, E.; Wright, S. D. Lipopolysaccharide binding protein and soluble CD14 catalyze exchange of phospholipids. J. Clin. Invest. 1997, 99, 315-324.
21. Wurfel, M. M.; Wright, S. D. Lipopolysaccharide (LPS) binding protein catalyzes binding of LPS to lipoproteins. Prog. Clin. Biol. Res. 1995, 392, 287-295.
22. Levels, J. H.; Abraham, P. R.; van den Ende, A.; van Deventer, S. J. Distribution and kinetics of lipoprotein-bound endotoxin. Infect. Immun. 2001, 69, 2821-2828.
23. Wurfel, M. M.; Monks, B. G.; Ingalls, R. R.; Dedrick, R. L.; Delude, R.; Zhou, D.; Lamping, N.; Schumann, R. R.; Thieringer, R.; Fenton, M. J.; Wright, S. D.; Golenbock, D. Targeted deletion of the lipopolysaccharide (LPS)-binding protein gene leads to profound suppression of LPS responses ex vivo, whereas in vivo responses remain intact. J. Exp. Med. 1997, 186, 2051-2056.
24. Jack, R. S.; Fan, X.; Bernheiden, M.; Rune, G.; Ehlers, M.; Weber, A.; Kirsch, G.; Mentel, R.; Furll, B.; Freudenberg, M.; Schmitz, G.; Stelter, F.; Schutt, C.. Lipopolysaccharide-binding protein is required to combat a murine gram-negative bacterial infection. Nature 1997, 389, 742-745.
25. Weiss, J.; Elsbach, P.; Shu, C.; Castillo, J.; Grinna, L.; Horwitz, A.; Theofan, G. Human bactericidal/permeability-increasing protein and a recombinant NH2-terminal fragment cause killing of serum-resistant gram-negative bacteria in whole blood and inhibit tumor necrosis factor release induced by the bacteria. J. Clin. Invest. 1992, 90, 1122-1130.
26. Tobias, P. S.; Mathison, J. C.; Ulevitch, R. J. A family of lipopolysaccharide binding proteins involved in responses to gram-negative sepsis. J. Biol. Chem. 1988, 263, 13479-13481.
27. Ooi, C. E.; Weiss, J.; Elsbach, P.; Frangione, B.; Mannion, B. A 25-kDa NH2-terminal fragment carries all the antibacterial activities of the human neutrophil 60-kDa bactericidal/permeability-increasing protein. J. Biol. Chem. 1987, 262, 14891-14894.
28. Gazzano-Santoro, H.; Parent, J. B.; Conlon, P. J.; Kasler, H. G.; Tsai, C.; M. Lill-Elghanian, D. A.; Hollingsworth, R. I. Characterization of the structural elements in lipid A required for binding of a recombinant fragment of bactericidal/permeability-increasing protein rBPI23 [published erratum appears in Infect Immun 1995 Dec;63[12]:4967]. Infect. Immun. 1995, 63, 2201-2205.
29. Elsbach, P.; Weiss, J. Role of the bactericidal/permeability-increasing protein in host defence. Curr. Opin. Immunol. 1998, 10, 45-49.
30. Wright, S. D.; Ramos, R. A.; Tobias, P. S.; Ulevitch, R. J.; Mathison, J. C. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein [see comments]. Science 1990, 249, 1431-1433.
31. Kirkland, T. N.; Finley, F.; Leturcq, D.; Moriarty, A.; Lee, J. D.; Ulevitch, R. J.; Tobias, P. S. Analysis of lipopolysaccharide binding by CD14. J. Biol. Chem. 1993, 268, 24818-24823.
32. Haziot, A.; Rong, G. W.; Silver, J.; Goyert, S. M. Recombinant soluble CD14 mediates the activation of endothelial cells by lipopolysaccharide. J. Immunol. 1993, 151, 1500-1507.
33. Faure, E.; Equils, O.; Sieling, P. A.; Thomas, L.; Zhang, F. X.; Kirschning, C. J.; Polentarutti, N.; Muzio, M.; Arditi, M. Bacterial lipopolysaccharide activates NF-kappaB through toll-like receptor 4 (TLR-4) in cultured human dermal endothelial cells. Differential expression of TLR-4 and TLR-2 in endothelial cells. J. Biol. Chem. 2000, 275, 11058-11063.
34. Haziot, A.; Ferrero, E.; Kontgen, F.; Hijiya, N.; Yamamoto Silver, J.; Stewart, C. L.; Goyert, S. M.. Resistance to endotoxin shock and reduced dissemination of gram-negative bacteria in CD14-deficient mice. Immunity 1996, 4, 407-414.
35. Golenbock, D. T.; Liu, Y.; Millham, F. H.; Freeman, M. W.; Zoeller, R. A. Surface expression of human CD14 in Chinese hamster ovary fibroblasts imparts macrophage-like responsiveness to bacterial endotoxin. J. Biol. Chem. 1993, 268, 22055-22059.
36. Lee, J. D.; Kato, K.; Tobias, P. S.; Kirkland, T. N.; Ulevitch, R. J. Transfection of CD14 into 70Z/3 cells dramatically enhances the sensitivity to complexes of lipopolysaccharide (LPS) and LPS binding protein. J. Exp. Med. 1992, 175, 1697-1705.
37. Viriyakosol, S.; Kirkland, T. N. A region of human CD14 required for lipopolysaccharide binding. J. Biol. Chem. 1995, 270, 361-368.
38. Williams, M. J.; Rodriguez, A.; Kimbrell, D. A.; Eldon, E. D. The 18-wheeler mutation reveals complex antibacterial gene regulation in Drosophila host defense. EMBO J. 1997, 16, 6120-6130.
39. Poltorak, A.; He, X.; Smirnova, I.; Liu, M. Y.; Van Huffel, C.; Du, X.; Birdwell, D.; Alejos, E.; Silva, M.; Galanos, C.; Freudenberg, M.; Ricciardi-Castagnoli, P.; Layton, B.; Beutler, B. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 1998, 282, 2085-2088.
40. Qureshi, S. T.; Lariviere, L.; Leveque, G.; Clermont, S.; Moore, K. J.; Gros, P.; Malo, D. Endotoxin-tolerant mice have mutations in Toll-like receptor 4 [Tlr4]. J. Exp. Med. 1999, 189, 615-625.
41. Medzhitov, R.; Preston-Hurlburt, P.; Janeway, C. A., Jr. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 1997, 388, 394-397.
42. Barton, G.; Medzhitov, R. Toll-like receptors and their ligands. Curr. Top. Microbiol. Immunol. 2002, 270, 81-92.
43. Yang, R. B.; Mark, M. R.; Gray, A.; Huang, A.; Xie, M. H.; Zhang, M.; Goddard, A.; Wood, W. I.; Gurney, A. L.; Godowski, P. J. Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling. Nature 1998, 395, 284-288.
44. da Silva Correia, J.; Soldau, K.; Christen, U.; Tobias, P. S.; Ulevitch, R. J. Lipopolysaccharide is in close proximity to each of the proteins in its membrane receptor complex transfer from CD14 to TLR4 and MD-2. J. Biol. Chem. 2001, 276, 21129-21135.
45. Shimazu, R.; Akashi, S.; Ogata, H.; Nagai, Y.; Fukudome, K.; Miyake, K.; Kimoto, M. MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J. Exp. Med. 1999, 189, 1777-1782.
46. Kawasaki, K.; Akashi, S.; Shimazu, R.; Yoshida, T.; Miyake, K.; Nishijima, M. Mouse toll-like receptor 4.MD-2 complex mediates lipopolysaccharide-mimetic signal transduction by Taxol. J. Biol. Chem. 2000, 275, 2251-2254.
47. Kawasaki, K.; Nogawa, H.; Nishijima, M. Identification of Mouse MD-2 Residues Important for Forming the Cell Surface TLR4-MD-2 Complex Recognized by Anti-TLR4-MD-2 Antibodies, and for Conferring LPS and Taxol Responsiveness on Mouse TLR4 by Alanine-Scanning Mutagenesis. J. Immunol. 2003, 170, 413-420.
48. Re, F.; Strominger, J. L. Monomeric recombinant MD-2 binds toll-like receptor 4 tightly and confers lipopolysaccharide responsiveness. J. Biol. Chem. 2002, 277, 23427-23432.
49. Lien, E.; Means, T. K.; Heine, H.; Yoshimura, A.; Kusumoto, S.; Fukase, K.; Fenton, M. J.; Oikawa, M.; Qureshi, N.; Monks, B.; Finberg, R. W.; Ingalls, R. R.; Golenbock, D. T. Toll-like receptor 4 imparts ligand-specific recognition of bacterial lipopolysaccharide. J. Clin. Invest. 2000, 105, 497-504.
50. Brown, M. S.; Goldstein, J. L. Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis. Annu. Rev. Biochem. 1983, 52, 223-261.
51. Dunne, D. W.; Resnick, D.; Greenberg, J.; Krieger, M.; Joiner, K. A. The type I macrophage scavenger receptor binds to gram-positive bacteria and recognizes lipoteichoic acid. Proc. Natl. Acad. Sci. USA 1994, 91, 1863-1867.
52. Wright, S. D.; Jong, M. T. Adhesion-promoting receptors on human macrophages recognize Escherichia coli by binding to lipopolysaccharide. J. Exp. Med. 1986, 164, 1876-1888.
53. Janeway, C. A., Jr. The immune system evolved to discriminate infectious nonself from noninfectious self. Immunol. Today 1992, 13, 11-16.
54. Aderem, A. A.; Wright, S. D.; Silverstein, S. C.; Cohn, Z. A. Ligated complement receptors do not activate the arachidonic acid cascade in resident peritoneal macrophages. J. Exp. Med. 1985, 161, 617-622.
55. Perera, P. Y.; Vogel, S. N.; Detore, G. R.; Haziot, A.; Goyert, S. M. CD14-dependent and CD14-independent signaling pathways in murine macrophages from normal and CD14 knockout mice stimulated with lipopolysaccharide or taxol. J. Immunol. 1997, 158, 4422-4429.
56. Wright, S. D.; Craigmyle, L. S.; Silverstein, S. C. Fibronectin and serum amyloid P component stimulate C3b- and C3bi-mediated phagocytosis in cultured human monocytes. J. Exp. Med. 1983, 158, 1338-1343.
57. Haworth, R.; Platt, N.; Keshav, S.; Hughes, D.; Darley, E.; Suzuki, H.; Kurihara, Y.; Kodama, T.; Gordon, S. The macrophage scavenger receptor type A is expressed by activated macrophages and protects the host against lethal endotoxic shock. J. Exp. Med. 1997, 186, 1431-1439.
58. Yamamoto, T.; Ebe, Y.; Hasegawa, G.; Kataoka, M.; Yamamoto, S.; Naito, M. Expression of scavenger receptor class A and CD14 in lipopolysaccharide-induced lung injury. Pathol. Int. 1999, 49, 983-992.
59. Kildsgaard, J.; Hollmann, T. J.; Matthews, K. W.; Bian, K.; Murad, F.; Wetsel, R. A. Cutting edge: targeted disruption of the C3a receptor gene demonstrates a novel protective anti-inflammatory role for C3a in endotoxin-shock. J. Immunol. 2000, 165, 5406-5409.
60. Sedwick, C. E.; Altman, A. Ordered just so: lipid rafts and lymphocyte function. Sci. STKE 2002, 2002, RE2.
61. Werlen, G.; Palmer, E. The T-cell receptor signalosome: a dynamic structure with expanding complexity. Curr. Opin. Immunol. 2002, 14, 299-305.
62. Pike, L. J. Lipid Rafts: Bringing Order to Chaos. J. Lipid. Res. 2003.
63. Edidin, M. The State of Lipid Rafts: From Model Membranes to Cells. Annu. Rev. Biophys. Biomol. Struct. 2003.
64. Triantafilou, K.; Triantafilou, M.; Ladha, S.; Mackie, A.; Dedrick, R. L.; Fernandez, N.; Cherry, R. Fluorescence recovery after photobleaching reveals that LPS rapidly transfers from CD14 to hsp70 and hsp90 on the cell membrane. J. Cell Sci. 2001, 114, 2535-2545.
65. Triantafilou, M.; Triantafilou, K. Lipopolysaccharide recognition: CD14, TLRs and the LPS-activation cluster. Trends Immunol. 2002, 23, 301-304.
66. Triantafilou, K.; Triantafilou, M.; Dedrick, R. L. A CD14-independent LPS receptor cluster. Nat. Immunol. 2001, 2, 338-345.
67. Pfeiffer, A.; Bottcher, A.; Orso, E.; Kapinsky, M.; Nagy, P.; Bodnar, A.; Spreitzer, I.; Liebisch, G.; Drobnik, W.; Gempel, K.; Horn, M.; Holmer, S.; Hartung, T.; Multhoff, G.; Schutz, G.; Schindler, H.; Ulmer, A. J.; Heine, H.; Stelter, F.; Schutt, C.; Rothe, G.; Szollosi, J.; Damjanovich, S.; Schmitz, G. Lipopolysaccharide and ceramide docking to CD14 provokes ligand-specific receptor clustering in rafts. Eur. J. Immunol. 2001, 31, 3153-3164.
68. Hornef, M. W.; Frisan, T.; Vandewalle, A.; Normark, S.; Richter-Dahlfors, A. Toll-like receptor 4 resides in the Golgi apparatus and colocalizes with internalized lipopolysaccharide in intestinal epithelial cells. J. Exp. Med. 2002, 195, 559-570.
69. Latz, E.; Visintin, A.; Lien, E.; Fitzgerald, K. A.; Monks, B. G.; Kurt-Jones, E. A.; Golenbock, D. T.; Espevik, T. Lipopolysaccharide Rapidly Traffics to and from the Golgi Apparatus with the Toll-like Receptor 4-MD-2-CD14 Complex in a Process That Is Distinct from the Initiation of Signal Transduction. J. Biol. Chem. 2002, 277, 47834-47843.
70. Peppelenbosch, M. P.; DeSmedt, M.; ten Hove, T.; van Deventer, S. J.; Grooten, J. Lipopolysaccharide regulates macrophage fluid phase pinocytosis via CD14-dependent and CD14-independent pathways. Blood 1999, 93, 4011-4018.
71. Buys, S. S.; Keogh, E. A.; Kaplan, J. Fusion of intracellular membrane pools with cell surfaces of macrophages stimulated by phorbol esters and calcium ionophores. Cell 1984, 38, 569-576.
72. Brown, W. J.; DeWald, D. B.; Emr, S. D.; Plutner, H.; Balch, W. E. Role for phosphatidylinositol 3-kinase in the sorting and transport of newly synthesized lysosomal enzymes in mammalian cells. J. Cell Biol. 1995, 130, 781-796.
73. Davidson, H. W. Wortmannin causes mistargeting of procathepsin D. evidence for the involvement of a phosphatidylinositol 3-kinase in vesicular transport to lysosomes. J. Cell Biol. 1995, 130, 797-805.
74. Hmama, Z.; Knutson, K. L.; Herrera-Velit, P.; Nandan, D.; Reiner, N. E. Monocyte adherence induced by lipopolysaccharide involves CD14, LFA-1, and cytohesin-1. Regulation by Rho and phosphatidylinositol 3-kinase. J. Biol. Chem. 1999, 274, 1050-1057.
75. Salh, B.; Wagey, R.; Marotta, A.; Tao, J. S.; Pelech, S. Activation of phosphatidylinositol 3-kinase, protein kinase B, and p70 S6 kinases in lipopolysaccharide-stimulated Raw 264.7 cells: differential effects of rapamycin, Ly294002, and wortmannin on nitric oxide production. J. Immunol. 1998, 16l, 6947-6954.
76. Williams, L. M.; Ridley, A. J. Lipopolysaccharide induces actin reorganization and tyrosine phosphorylation of pyk2 and paxillin in monocytes and macrophages [In Process Citation]. J. Immunol. 2000, 164, 2028-2036.
77. Vieira, O. V.; Botelho, R. J.; Rameh, L.; Brachmann, S. M.; Matsuo, T.; Davidson, H. W.; Schreiber, A.; Backer, J. M.; Cantley, L. C.; Grinstein, S. Distinct roles of class I and class III phosphatidylinositol 3-kinases in phagosome formation and maturation. J. Cell Biol. 2001, 155, 19-25.
78. Underhill, D. M.; Ozinsky, A. Phagocytosis of microbes: complexity in action. Annu. Rev. Immunol. 2002, 20, 825-852.
79. Werts, C.; Tapping, R. I.; Mathison, J. C.; Chuang, T. H.; Kravchenko, V.; Saint Girons, I.; Haake, D. A.; Godowski, P. J.; Hayashi, F.; Ozinsky, A.; Underhill, D. M.; Kirschning, C. J.; Wagner, H.; Aderem, A.; Tobias, P. S.; Ulevitch, R. J. Leptospiral lipopolysaccharide activates cells through a TLR2-dependent mechanism. Nat. Immunol. 2001, 2, 346-352.
80. Aderem, A.; Ulevitch, R. J. Toll-like receptors in the induction of the innate immune response. Nature 2000, 406, 782-787.
81. Underhill, D. M.; Ozinsky, A. Toll-like receptors: key mediators of microbe detection. Curr. Opin. Immunol. 2002, 14, 103-110.
82. Huang, Q.; Liu, D.; Majewski, P.; Schulte, L. C.; Korn, J. M.; Young, R. A.; Lander, E. S.; Hacohen, N. The plasticity of dendritic cell responses to pathogens and their components. Science 2001, 294, 870-875.
83. Belvin, M. P.; Anderson, K. V. A conserved signaling pathway: the Drosophila toll-dorsal pathway. Annu. Rev. Cell Dev. Biol. 1996, 12, 393-416.
84. Wesche, H.; Henzel, W. J.; Shillinglaw, W.; Li, S.; Cao, Z. MyD88: an adapter that recruits IRAK to the IL-1 receptor complex. Immunity 1997, 7, 837-847.
85. Burns, K.; Martinon, F.; Esslinger, C.; Pahl, H.; Schneider, P.; Bodmer, J. L.; Di Marco, F.; French, L.; Tschopp, J. MyD88, an adapter protein involved in interleukin-1 signaling. J. Biol. Chem. 1998, 273, 12203-12209.
86. Medzhitov, R.; Preston-Hurlburt, P.; Kopp, E.; Stadlen, A.; Chen, C.; Ghosh, S.; Janeway, C. A., Jr. MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways. Mol. Cell 1998, 2, 253-258.
87. Kawai, T.; Adachi, O.; Ogawa, T.; Takeda, K.; Akira, S. Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 1999, 11, 115-122.
88. Takeuchi, O.; Takeda, K.; Hoshino, K.; Adachi, O.; Ogawa, T.; Akira, S. Cellular responses to bacterial cell wall components are mediated through MyD88-dependent signaling cascades. Int. Immunol. 2000, 12, 113-117.
89. Akira, S.; Hoshino, K.; Kaisho, T. The role of Toll-like receptors and MyD88 in innate immune responses. J. Endotoxin. Res. 2000, 6, 383-387.
90. Kawai, T.; Takeuchi, O.; Fujita, T.; Inoue, J.; Muhlradt, P. F.; Sato, S.; Hoshino, K.; Akira, S. Lipopolysaccharide stimulates the MyD88-independent pathway and results in activation of IFN-regulatory factor 3 and the expression of a subset of lipopolysaccharide-inducible genes. J. Immunol. 2001, 167, 5887-5894.
91. Moriguchi, T.; Kuroyanagi, N.; Yamaguchi, K.; Gotoh, Y.; Irie, K.; Kano, T.; Shirakabe, K.; Muro, Y.; Shibuya, H.; Matsumoto, K.; Nishida, E.; Hagiwara, M A novel kinase cascade mediated by mitogen-activated protein kinase kinase 6 and MKK3. J. Biol. Chem. 1996, 271, 13675-13679.
92. Horng, T.; Barton, G. M.; Medzhitov, R. TIRAP: an adapter molecule in the Toll signaling pathway. Nat. Immunol. 2001, 2, 835-841.
93. Fitzgerald, K. A.; Palsson-McDermott, E. M.; Bowie, A. G.; Jefferies, C. A.; Mansell, A. S.; Brady, G.; Brint, E.; Dunne, A.; Gray, P.; Harte, M. T.; McMurray, D.; Smith, D. E.; Sims, J. E.; Bird, T. A.; O'Neill, L. A. Mal [MyD88-adapter-like] is required for Toll-like receptor-4 signal transduction. Nature 2001, 413, 78-83.
94. Goh, K. C.; deVeer, M. J.; Williams, B. R. The protein kinase PKR is required for p38 MAPK activation and the innate immune response to bacterial endotoxin. EMBO J. 2000, 19, 4292-4297.
95. Navarro, L.; David, M. p38-dependent activation of interferon regulatory factor 3 by lipopolysaccharide. J. Biol. Chem. 1999, 274, 35535-35538.
96. Doyle, S.; Vaidya, S.; O'Connell, R.; Dadgostar, H.; Dempsey, P.; Wu, T.; Rao, G.; Sun, R.; Haberland, M.; Modlin, R.; Cheng, G. IRF3 mediates a TLR3/TLR4-specific antiviral gene program. Immunity 2002, 17, 251-263.
97. Shinobu, N.; Iwamura, T.; Yoneyama, M.; Yamaguchi, K.; Suhara, W.; Fukuhara, Y.; Amano, F.; Fujita, T. Involvement of TIRAP/MAL in signaling for the activation of interferon regulatory factor 3 by lipopolysaccharide. FEBS Lett. 2002, 517, 251-256.
98. Yamamoto, M.; Sato, S.; Mori, K.; Hoshino, K.; Takeuchi, O.; Takeda, K.; Akira, S. Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling. J. Immunol. 2002, 169, 6668-6672.
99. O'Neill LA. The role of MyD88-like adapters in Toll-like receptor signal transduction. Biochem. Soc. Trans 2003, 3, 643-7.
100. O'Neill LA.; Fitzgerald KA.; Bowie AG. The Toll-IL-1 receptor adaptor family grows to five members. Trends Immunol. 2003, 6, 286-90
101. Muzio, M.; Ni, J.; Feng, P.; Dixit, V. M. IRAK [Pelle] family member IRAK-2 and MyD88 as proximal mediators of IL-1 signaling. Science 1997, 278, 1612-1615.
102. Kobayashi, K.; Hernandez, L. D.; Galan, J. E.; Janeway, C. A., Jr.; Medzhitov, R.; Medzhitov, R.; Flavell, R. A. IRAK-M is a negative regulator of Toll-like receptor signaling. Cell 2002, 110, 191-202.
103. Li, S.; Strelow, A.; Fontana, E. J.; Wesche, H. IRAK-4: a novel member of the IRAK family with the properties of an IRAK-kinase. Proc. Natl. Acad. Sci. USA 2002, 99, 5567-5572.
104. Burns, K.; Clatworthy, J.; Martin, L.; Martinon, F.; Plumpton, C.; Maschera, B.; Lewis, A.; Ray, K.; Tschopp, J.; Volpe, F. Tollip, a new component of the IL-IRI pathway, links IRAK to the IL-1 receptor. Nat. Cell Biol. 2000, 2, 346-351.
105. Zhang, G.; Ghosh, S. Negative regulation of toll-like receptor-mediated signaling by Tollip. J. Biol. Chem. 2002, 277, 7059-7065.
106. Cao, Z.; Henzel, W. J.; Gao, X. IRAK: a kinase associated with the interleukin-1 receptor. Science 1996, 271, 1128-1131.
107. Cao, Z.; Xiong, J.; Takeuchi, M.; Kurama, T.; Goeddel, D. V. TRAF6 is a signal transducer for interleukin-1. Nature 1996, 383, 443-446.
108. Jiang, Z.; Ninomiya-Tsuji, J.; Qian, Y.; Matsumoto, K.; Li, X. Interleukin-1 [IL-1] receptor-associated kinase-dependent IL-1-induced signaling complexes phosphorylate TAK1 and TAB2 at the plasma membrane and activate TAK1 in the cytosol. Mol. Cell Biol. 2002, 22, 7158-7167.
109. Ninomiya-Tsuji, J.; Kishimoto, K.; Hiyama, A.; Inoue, J.; Cao, Z.; Matsumoto, K. The kinase TAK1 can activate the NIK-I κB as well as the MAP kinase cascade in the IL-1 signalling pathway. Nature 1999, 398, 252-256.
110. Irie, T.; Muta, T.; Takeshige, K. TAK1 mediates an activation signal from toll-like receptor[s] to nuclear factor-κB in lipopolysaccharide-stimulated macrophages [In Process Citation]. FEBS Lett. 2000, 467, 160-164.
111. McDermott, E. P.; O'Neill, L. A. Ras participates in the activation of p38 MAPK by interleukin-1 by associating with IRAK, IRAK2, TRAF6, and TAK-1. J. Biol. Chem. 2002, 277, 7808-7815.
112. Kopp, E. B.; Medzhitov, R. The Toll-receptor family and control of innate immunity. Curr. Opin. Immunol. 1999, 11, 13-18.
113. Lee, F. S.; Peters, R. T.; Dang, L. C.; Maniatis, T. MEKK1 activates both IκB kinase alpha and IκB kinase beta. Proc. Natl. Acad. Sci. USA 1998, 95, 9319-9324.
114. Chen, Z. J.; Parent, L.; Maniatis, T. Site-specific phosphorylation of IκBalpha by a novel ubiquitination-dependent protein kinase activity. Cell 1996, 84, 853-862.
115. Cohen, L.; Henzel, W. J.; Baeuerle, P. A. IKAP is a scaffold protein of the IκB kinase complex [see comments]. Nature 1998, 395, 292-296.
116. Rothwarf, D. M.; Zandi, E.; Natoli, G.; Karin, M. IKK-gamma is an essential regulatory subunit of the IκB kinase complex [see comments]. Nature 1998, 395, 297-300.
117. Yamaoka, S.; Courtois, G.; Bessia, C.; Whiteside, S. T.; Weil, R.; Agou, F.; Kirk, H. E.; Kay, R. J.; Israel, A. Complementation cloning of NEMO, a component of the IκB kinase complex essential for NF-κB activation. Cell 1998, 93, 1231-1240.
118. Regnier, C. H.; Song, H. Y.; Gao, X.; Goeddel, D. V.; Cao, Z.; Rothe, M. Identification and characterization of an IkappaB kinase. Cell 1997, 90, 373-383.
119. Mercurio, F.; Zhu, H.; Murray, B. W.; Shevchenko, A.; Bennett, B. L.; Li, J.; Young, D. B.; Barbosa, M.; Mann, M.; Manning, A.; Rao, A. IKK-1 and IKK-2: cytokine-activated IkappaB kinases essential for NF-kappaB activation. Science 1997, 278, 860-866.
120. Shimada, T.; Kawai, T.; Takeda, K.; Matsumoto, M.; Inoue, J.; Tatsumi, Y.; Kanamaru, A.; Akira, S. IKK-i, a novel lipopolysaccharide-inducible kinase that is related to IκB kinases. Int. Immunol. 1999, 11, 1357-1362.
121. Ghosh, S.; May, M. J.; Kopp, E. B. NF-κB and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 1998, 16, 225-260.
122. Ridley, A. J. The GTP-binding protein Rho. Int. J. Biochem. Cell Biol. 1997, 29, 1225-1229.
123. Ridley, A. J. Rho: theme and variations. Curr. Biol. 1996, 6, 1256-1264.
124. Symons, M. Rho family GTPases: the cytoskeleton and beyond. Trends Biochem. Sci. 1996, 21, 178-181.
125. Chen, L. Y.; Zuraw, B. L.; Liu, F. T.; Huang, S.; Pan, Z. K. IL-1 receptor-associated kinase and low molecular weight GTPase RhoA signal molecules are required for bacterial lipopolysaccharide-induced cytokine gene transcription. J. Immunol. 2002, 169, 3934-3939.
126. Arbibe, L.; Mira, J. P.; Teusch, N.; Kline, L.; Guha, M.; Mackman, N.; Godowski, P. J.; Ulevitch, R. J.; Knaus, U. G. Toll-like receptor 2-mediated NF-κ B activation requires a Rac1-dependent pathway. Nat. Immunol. 2000, 1, 533-540.
127. Tohme, Z. N.; Amar, S.; Van Dyke, T. E. Moesin functions as a lipopolysaccharide receptor on human monocytes. Infect. Immun. 1999, 67, 3215-3220.
128. Speck, O.; Hughes, S. C.; Noren, N. K.; Kulikauskas, R. M.; Fehon, R. G. Moesin functions antagonistically to the Rho pathway to maintain epithelial integrity. Nature 2003, 421, 83-87.
129. Thieblemont, N.; Wright, S. D. Transport of bacterial lipopolysaccharide to the golgi apparatus. J. Exp. Med. 1999, 190, 523-534.
130. Weinrauch, Y.; Katz, S. S.; Munford, R. S.; Elsbach, P.; Weiss, J. Deacylation of purified lipopolysaccharides by cellular and extracellular components of a sterile rabbit peritoneal inflammatory exudate. Infect. Immun. 1999, 67, 3376-3382.
131. Munford, R. S.; Hall, C. L. Detoxification of bacterial lipopolysaccharides (endotoxins) by a human neutrophil enzyme. Science 1986, 234, 203-205.
132. Munford, R. S.; Hunter, J. P. Acyloxyacyl hydrolase, a leukocyte enzyme that deacylates bacterial lipopolysaccharides, has phospholipase, lysophospholipase, diacylglycerollipase, and acyltransferase activities in vitro. J. Biol. Chem. 1992, 267, 10116-10121.
133. Kitchens, R. L.; Munford, R. S. Enzymatically deacylated lipopolysaccharide (LPS) can antagonize LPS at multiple sites in the LPS recognition pathway. J. Biol. Chem. 1995, 270, 9904-9910.
134. Perdigon, G.; Fuller, R.; Raya, R. Lactic acid bacteria and their effect on the immune system. Curr. Issues Intest. Microbiol. 2001, 2, 27-42.
135. Isolauri, E. Probiotics in human disease. Am. J. Clin. Nutr. 2001, 73, 1142S-1146S.
136. Cross, M. L. Microbes versus microbes: immune signals generated by probiotic lactobacilli and their role in protection against microbial pathogens. FEMS Immunol. Med. Microbiol. 2002, 34, 245-253.
137. Ogata H.; Su, I.; Miyake, K.; Nagai, Y.; Akashi, S.; Mecklenbrauker, I.; Rajewsky, K.; Kimoto, M.; Tarakhovsky, A. The Toll-like receptor protein RP105 regulates lipopolysaccharide signalling in B cells. J. Exp. Med. 2000, 192, 23-29.
138. McCurdy, J.D.; Lin, T.J.; Marshall, J.S. Toll-like receptor 4-mediated activation of murine mast cells. J. Leukoc. Biol. 2001, 70, 977-984